New tumour-marker report

Complete the seven sections; the four-axis interpretation grade is computed on submit.

  1. Identification
  2. Specimen
  3. Values
  4. Trend
  5. Findings
  6. Impression
  7. Sign-off
1. Report Identification

Who authored the report, the originating request, and key dates.

2. Specimen & Context

Specimen condition, clinical history, and any known cancer site.

3. Measured Values

Enter each measured serum tumour marker. Leave a field blank when the marker was not measured.

Prostate cancer; informed-choice testing.

Suspected ovarian cancer (NICE CG122 ultrasound threshold 35 IU/mL).

Pancreatic / hepatobiliary cancer (reference < 37 U/mL).

Colorectal cancer monitoring.

Hepatocellular / germ-cell tumours; a very high value suggests a germ-cell tumour.

Germ-cell / trophoblastic tumours; a very high value suggests a germ-cell tumour.

Breast cancer monitoring.

Germ-cell tumour staging; lymphoma prognosis.

Medullary thyroid carcinoma.

Neuroendocrine tumours.

4. Trend

Comparison with the previous value drives the monitoring / response interpretation.

Most recent previous value of the principal marker, for trend interpretation.

5. Findings

The narrative findings, markedly-elevated flag, and overall result status.

6. Impression

The summary impression, reporting category, and recommended follow-up.

Structured-reporting category label (e.g. a germ-cell-marker pattern or monitoring-trend category).

7. Interpretation & Sign-off

Live four-axis interpretation grade, critical-result communication, and sign-off.

Axis A — Classification
Inconclusive
Axis B — Severity
None indeterminate
Axis C — Completeness
0%
Axis D — Follow-up urgency
Recommended
within 4 weeks